SCHEMBL8104038

SCHEMBL8104038

CC(C)NC(=O)Nc1ccc(-c2nc(N)cc(C3(S(=O)(=O)C(C)(C)C)CC3)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA9 Q16790 2/20 0.41
GHSR Q92847 2/20 0.38
PIK3CD O00329 7/20 0.37
PIK3CA P42336 2/20 0.37
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
ROCK2 O75116 2/20 0.36
CYP3A4 P08684 1/20 0.35
CYP3A5 P20815 1/20 0.35
LIMK1 P53667 2/20 0.34
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8098188 0.89 CA12 (0.44) CA12CA1CA2CA9GHSR
SCHEMBL8089531 0.88 CA12 (0.43) CA12CA1CA2CA9GHSR
SCHEMBL8090572 0.88 PIK3CD (0.41) PIK3CDPIK3CAEPHX2
SCHEMBL8091998 0.87 KIF11 (0.40) PIK3CDPIK3CAKDM4EMEN1ALDH1A1
SCHEMBL8097252 0.86 CA12 (0.43) CA12CA1CA2CA9GHSR
SCHEMBL8091781 0.86 CA12 (0.43) CA12CA1CA2CA9GHSR
SCHEMBL8097694 0.86 CYP3A4 (0.42) CA12CA1CA2CA9PIK3CD
SCHEMBL8106295 0.85 CA12 (0.42) CA12CA1CA2CA9GHSR
SCHEMBL8096016 0.85 PIK3CD (0.43) GHSRPIK3CDPIK3CAHDAC3HDAC1
SCHEMBL8096026 0.85 POLB (0.40) PIK3CDPIK3CAKDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009007748-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed